Louis Chesler
Affiliations: | University of California, San Francisco, San Francisco, CA |
Google:
"Louis Chesler"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ferguson KM, Gillen SL, Chaytor L, et al. (2023) Palbociclib releases the latent differentiation capacity of neuroblastoma cells. Developmental Cell |
| Tsakaneli A, Carregari VC, Morini M, et al. (2021) MYC regulates metabolism through vesicular transfer of glycolytic kinases. Open Biology. 11: 210276 |
| Urban-Wójciuk Z, Graham A, Barker K, et al. (2021) The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme. Cancer Gene Therapy |
| Shrestha S, Morcavallo A, Gorrini C, et al. (2021) Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead. Frontiers in Oncology. 11: 694320 |
| Ingley KM, Hughes D, Hubank M, et al. (2021) Durable response to serial tyrosine kinase inhibitors (TKIs) in an adolescent with metastatic TFG-ROS1 fusion positive Inflammatory Myofibroblastic Tumor (IMT). Lung Cancer (Amsterdam, Netherlands) |
| Dubiella C, Pinch BJ, Koikawa K, et al. (2021) Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nature Chemical Biology |
| Roeschert I, Poon E, Henssen AG, et al. (2021) Combined inhibition of Aurora-A and ATR kinase results in regression of -amplified neuroblastoma. Nature Cancer. 2: 312-326 |
| Morcavallo A, Barker K, Adachi T, et al. (2021) TMOD-03. A NOVEL MB GR3 TRANSGENIC MOUSE MODEL IS GENERATED BY MYCN AND P53 DEFECTS IN VENTRICULAR ZONE PROGENITORS. Neuro-Oncology. 23: i36-i36 |
| Poon E, Liang T, Jamin Y, et al. (2020) Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma. The Journal of Clinical Investigation |
| Caravagna G, Heide T, Williams MJ, et al. (2020) Subclonal reconstruction of tumors by using machine learning and population genetics. Nature Genetics. 52: 898-907 |